Talat Imran's most recent trade in Rani Therapeutics Holdings Inc - Ordinary Shares Class A was a trade of 35,000 Class A Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on July 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 17 Jul 2026 | 35,000 | 469,736 | - | 0.7 | 25,193 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 3,800,000 | 3,800,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 1,053,000 | 1,053,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.81 per share. | 27 Dec 2024 | 9,099 | 442,663 | - | 0.8 | 7,370 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 27 Dec 2024 | 9,077 | 468,584 | - | 0.5 | 4,357 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. | 27 Dec 2024 | 9,076 | 477,661 | - | 0.6 | 4,992 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 27 Dec 2024 | 8,916 | 451,762 | - | 1.1 | 10,075 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 27 Dec 2024 | 8,014 | 486,737 | - | 1.4 | 11,300 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.74 per share. | 27 Dec 2024 | 7,927 | 434,736 | - | 0.7 | 5,866 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 27 Dec 2024 | 7,906 | 460,678 | - | 1.4 | 11,068 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 09 Dec 2024 | 10,296 | 494,751 | - | 1.9 | 19,974 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 1,085,000 | 1,085,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 479,667 | 95,933 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 479,667 | 479,667 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 271,875 | 453,125 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 271,875 | 271,875 | - | - | 271875 | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 153,650 | 109,750 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 153,650 | 153,650 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 31,252 | 47,699 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 31,252 | 31,252 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 06 Dec 2023 | 10,000 | 484,455 | - | 2.3 | 22,700 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Imran Talat | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 04 Dec 2023 | 5,000 | 474,455 | - | 2.6 | 12,850 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 575,600 | 575,600 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 353,500 | 444,445 | - | 0 | Class A Common Stock | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 22 Mar 2023 | 7,988 | 90,945 | - | 6.0 | 47,529 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 263,400 | 263,400 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 86,600 | 98,943 | - | 0 | Class A Common Stock | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Feb 2022 | 827,467 | 0 | - | 0 | Class A Common Stock | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 03 Feb 2022 | 12,343 | 12,343 | - | 0 | Class A Common Stock | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 725,000 | 725,000 | - | - | Stock Option (Right to Buy) |